In one previous study, the author found that rs733618 and rs4553808 polymorphisms in CTLA-4 increased the breast cancer risk whereas rs231775 and rs3087243 polymorphisms did not have significant associations with breast cancer risk (Li et al., 2012). This evidence concerns the gene CTLA4 and breast carcinoma.